Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $60,425,000 | $54,638,000 | $48,894,000 | $46,987,000 |
| % Growth | 10.6% | 11.7% | 4.1% | – |
| Cost of Goods Sold | $33,718,000 | $31,880,000 | $25,516,000 | $22,648,000 |
| Gross Profit | $26,707,000 | $22,758,000 | $23,378,000 | $24,339,000 |
| % Margin | 44.2% | 41.7% | 47.8% | 51.8% |
| R&D Expenses | $2,824,000 | $3,490,000 | $1,661,000 | $832,000 |
| G&A Expenses | $2,290,000 | $2,033,000 | $1,707,000 | $0 |
| SG&A Expenses | $4,250,000 | $3,615,000 | $3,288,000 | $4,187,000 |
| Sales & Mktg Exp. | $1,960,000 | $1,582,000 | $1,581,000 | $4,187,000 |
| Other Operating Expenses | $12,835,000 | $10,618,000 | $12,886,000 | $14,660,000 |
| Operating Expenses | $19,909,000 | $17,723,000 | $17,835,000 | $19,679,000 |
| Operating Income | $6,798,000 | $5,035,000 | $5,540,000 | $4,656,000 |
| % Margin | 11.3% | 9.2% | 11.3% | 9.9% |
| Other Income/Exp. Net | -$73,000 | $558,000 | $182,000 | $111,000 |
| Pre-Tax Income | $6,725,000 | $5,593,000 | $5,722,000 | $4,767,000 |
| Tax Expense | $1,682,000 | $1,473,000 | $1,778,000 | $1,392,000 |
| Net Income | $5,042,000 | $4,119,000 | $3,944,000 | $3,374,000 |
| % Margin | 8.3% | 7.5% | 8.1% | 7.2% |
| EPS | 179.46 | 146.57 | 140.38 | 120.11 |
| % Growth | 22.4% | 4.4% | 16.9% | – |
| EPS Diluted | 179.46 | 146.57 | 140.38 | 120.11 |
| Weighted Avg Shares Out | 28,109 | 28,103 | 28,096 | 28,090 |
| Weighted Avg Shares Out Dil | 28,109 | 28,103 | 28,096 | 28,090 |
| Supplemental Information | – | – | – | – |
| Interest Income | $357,000 | $287,000 | $167,000 | $144,000 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $408,000 | $459,000 | $252,000 | $279,000 |
| EBITDA | $7,133,000 | $6,052,000 | $5,975,000 | $5,047,000 |
| % Margin | 11.8% | 11.1% | 12.2% | 10.7% |